Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Temperature-related complaints like chills and hot flashes appeared consistently enough in real-world reports to be notable, but the study does not establish that these symptoms are caused by the medications
This study is part of a larger project that received ethical approval, allowing multiple related publications under a single Ethical Approval
Its also crucial to speak with your healthcare team if you experience persistent nausea or vomiting or notice any dental changes
Cesar de la Fuente-Nunez acknowledges support by the NIH R35GM138201, and DTRA HDTRA1-21-1-0014
Based on the current clinical trial timeline, retatrutide Phase 3 trial results are expected to be published in late 2026 or 2027
US$ 24.36
US$ 25.64
US$ 22.92
US$ 25.11
US$ 29.70
US$ 22.60
US$ 27.41
